Long-Term Clinical Outcomes of Sirolimus- Versus Paclitaxel-Eluting Stents for Patients With Unprotected Left Main Coronary Artery Disease. Analysis of the MAIN-COMPARE (Revascularization for Unprotected Left Main Coronary Artery Stenosis: Comparison of Percutaneous Coronary Angioplasty Versus Surgical Revascularization) Registry

Journal of the American College of Cardiology

Volumn 54, Issue 9, 2009, Pages 853-859

  Lee, Jong Young ^a   Park, Duk Woo ^a   Yun, Sung Cheol ^a   Lee, Seung Whan ^a   Kim, Young Hak ^a   Lee, Cheol Whan ^a   Hong, Myeong Ki ^a   Park, Seong Wook ^a   Park, Seung Jung ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

drug eluting stent; left main coronary artery disease; PCI

Indexed keywords

PACLITAXEL; RAPAMYCIN;

ARTICLE; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; FOLLOW UP; HAZARD RATIO; HEART INFARCTION; HUMAN; IMPLANTATION; PRIORITY JOURNAL; REVASCULARIZATION; RISK ASSESSMENT; STENOSIS; STENT; STENT THROMBOSIS; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY DISEASE; CORONARY STENOSIS; DRUG-ELUTING STENTS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PACLITAXEL; SIROLIMUS; TREATMENT OUTCOME; TUBULIN MODULATORS;

EID: 68749087459     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.04.071     Document Type: Article

References (37)

1. Eagle K.A., Guyton R.A., Davidoff R., et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). J Am Coll Cardiol 44 (2004) e213-e310
2. Smith Jr. S.C., Feldman T.E., Hirshfeld Jr. J.W., et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention). J Am Coll Cardiol 3 (2006) 47:e1-e121
3. Patel M., Dehmer G., Hirshfeld J., Smith P., and Spertus J. ACCF/SCAI/STS/AATS/AHA/ASNC 2009 appropriateness criteria for coronary revascularization: a report by the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography. J Am Coll Cardiol 53 (2009) 530-553
4. Park S.J., Park S.W., Hong M.K., et al. Stenting of unprotected left main coronary artery stenoses: immediate and late outcomes. J Am Coll Cardiol 31 (1998) 37-42
5. Park S.J., Hong M.K., Lee C.W., et al. Elective stenting of unprotected left main coronary artery stenosis: effect of debulking before stenting and intravascular ultrasound guidance. J Am Coll Cardiol 38 (2001) 1054-1060
6. Silvestri M., Barragan P., Sainsous J., et al. Unprotected left main coronary artery stenting: immediate and medium-term outcomes of 140 elective procedures. J Am Coll Cardiol 35 (2000) 1543-1550
7. Black A., Cortina R., Bossi I., Choussat R., Fajadet J., and Marco J. Unprotected left main coronary artery stenting: correlates of midterm survival and impact of patient selection. J Am Coll Cardiol 37 (2001) 832-838
8. Park S.J., Seung K.B., Park D.W., et al. Stents versus coronary-artery bypass grafting for left main coronary artery disease. N Engl J Med 358 (2008) 1781-1792
9. Chieffo A., Stankovic G., Bonizzoni E., et al. Early and mid-term results of drug-eluting stent implantation in unprotected left main. Circulation 111 (2005) 791-795
10. Park S.J., Kim Y.H., Lee B.K., et al. Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis: comparison with bare metal stent implantation. J Am Coll Cardiol 45 (2005) 351-356
11. Valgimigli M., van Mieghem C.A., Ong A.T., et al. Short- and long-term clinical outcome after drug-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: insights from the Rapamycin-Eluting and Taxus Stent Evaluated At Rotterdam Cardiology Hospital registries (RESEARCH and T-SEARCH). Circulation 111 (2005) 1383-1389
12. Ge L., Cosgrave J., Iakovou I., et al. Long-term outcomes following drug-eluting stent implantation in unprotected left main bifurcation lesions. Chin Med J (Engl) 120 (2007) 545-551
13. Sheiban I., Meliga E., Moretti C., et al. Long-term clinical and angiographic outcomes of treatment of unprotected left main coronary artery stenosis with sirolimus-eluting stents. Am J Cardiol 100 (2007) 431-435
14. Kim Y.H., Dangas G.D., Solinas E., et al. Effectiveness of drug-eluting stent implantation for patients with unprotected left main coronary artery stenosis. Am J Cardiol 101 (2008) 801-806
15. Chieffo A., Morici N., Maisano F., et al. Percutaneous treatment with drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis: a single-center experience. Circulation 113 (2006) 2542-2547
16. Biondi-Zoccai G.G., Lotrionte M., Moretti C., et al. A collaborative systematic review and meta-analysis on 1278 patients undergoing percutaneous drug-eluting stenting for unprotected left main coronary artery disease. Am Heart J 155 (2008) 274-283
17. Park S.-J., Lee C.W., Kim Y.-H., et al. Technical feasibility, safety, and clinical outcome of stenting of unprotected left main coronary artery bifurcation narrowing. Am J Cardiol 90 (2002) 374-378
18. Cutlip D.E., Windecker S., Mehran R., et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115 (2007) 2344-2351
19. Cox D. Regression models and life tables. J R Stat Soc B 34 (1972) 187-220
20. Cain K.C., and Lange N.T. Approximate case influence for the proportional hazards regression model with censored data. Biometrics 40 (1984) 493-499
21. D'Agostino Jr. R.B. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 17 (1998) 2265-2281
22. Yusuf S., Zucker D., Peduzzi P., et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 344 (1994) 563-570
23. Chaitman B.R., Fisher L.D., Bourassa M.G., et al. Effect of coronary bypass surgery on survival patterns in subsets of patients with left main coronary artery disease. Report of the Collaborative Study in Coronary Artery Surgery (CASS). Am J Cardiol 48 (1981) 765-777
24. Takaro T., Peduzzi P., Detre K.M., et al. Survival in subgroups of patients with left main coronary artery disease. Veterans Administration Cooperative Study of Surgery for Coronary Arterial Occlusive Disease. Circulation 66 (1982) 14-22
25. Caracciolo E.A., Davis K.B., Sopko G., et al. Comparison of surgical and medical group survival in patients with left main equivalent coronary artery disease. Long-term CASS experience. Circulation 91 (1995) 2335-2344
26. Chieffo A., Park S.J., Valgimigli M., et al. Favorable long-term outcome after drug-eluting stent implantation in nonbifurcation lesions that involve unprotected left main coronary artery: a multicenter registry. Circulation 116 (2007) 158-162
27. Meliga E., Garcia-Garcia H.M., Valgimigli M., et al. Impact of drug-eluting stent selection on long-term clinical outcomes in patients treated for unprotected left main coronary artery disease: the sirolimus vs paclitaxel drug-eluting stent for left main registry (SP-DELFT). Int J Cardiol (2008 Aug 6) [E-pub ahead of print]
28. Valgimigli M., Malagutti P., Aoki J., et al. Sirolimus-eluting versus paclitaxel-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: a combined RESEARCH and T-SEARCH long-term analysis. J Am Coll Cardiol 47 (2006) 507-514
29. Mehilli J Kastrati A., Byrne R.A., et al. LEFT-MAIN Intracoronary Stenting and Angiographic Results: Drug-Eluting Stents for Unprotected Coronary Left Main Lesions Study Investigators. Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease: ISAR-LEFT MAIN trial. J Am Coll Cardiol 53 (2009) 1760-1768
30. Morice M.C., Colombo A., Meier B., et al. Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial. JAMA 295 (2006) 895-904
31. Kastrati A., Dibra A., Eberle S., et al. Sirolimus-eluting stents vs paclitaxel-eluting stents in patients with coronary artery disease: meta-analysis of randomized trials. JAMA 294 (2005) 819-825
32. Lagerqvist B., James S.K., Stenestrand U., Lindback J., Nilsson T., and Wallentin L. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med 356 (2007) 1009-1019
33. Stone G.W., Moses J.W., Ellis S.G., et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 356 (2007) 998-1008
34. Mauri L., Hsieh W.H., Massaro J.M., Ho K.K., D'Agostino R., and Cutlip D.E. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 356 (2007) 1020-1029
35. Chieffo A., Park S.J., Meliga E., et al. Late and very late stent thrombosis following drug-eluting stent implantation in unprotected left main coronary artery: a multicentre registry. Eur Heart J 29 (2008) 2108-2115
36. Meliga E., Garcia-Garcia H.M., Valgimigli M., et al. Longest available clinical outcomes after drug-eluting stent implantation for unprotected left main coronary artery disease: the DELFT (Drug Eluting stent for LeFT main) Registry. J Am Coll Cardiol 51 (2008) 2212-2219
37. Daemen J., Wenaweser P., Tsuchida K., et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet 369 (2007) 667-678